Cyberounds Logo
December 10, 2018 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Diagnosis and Treatment of Kidney Cancer (preview)
CME credit is no longer available for this conference.
Robert H. Weiss, M.D. and Hiromi Inoue, D.V.M.

Dr. Weiss is Professor of Medicine, University of California, Davis, and Chief of Nephrology, Sacramento VA Medical Center, Sacramento, CA, and Dr. Inoue is a graduate student in comparative pathology, University of California, Davis.

Within the past 12 months Drs. Weiss and Inoue report no commercial conflicts of interest.

Albert Einstein College of Medicine, CCME staff and interMDnet staff have nothing to disclose.


Release Date: 01/31/2011
Termination Date: 01/31/2014

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • List the common presentation(s) of kidney cancer, as well as research into novel diagnostic approaches;
  • Apply the basic work-up of kidney cancer to patients who may have the disease;
  • Discuss and apply the basic principles and drugs useful in treatment of localized and metastatic kidney cancer.

 
The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity